Project Grant R37CA288492

Award Date 5/1/24
Completion Date 4/30/29
Dollars Obligated $595K
Federal Grant Program
93.353
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), provides $192,610 to The University of Kentucky Research Foundation to evaluate the impact of social determinants of health (SDOH) on early-onset colorectal cancer (EOCRC) diagnosis, treatment delays, and survival outcomes, with a focus on underserved populations in Kentucky and Georgia. The study aims to elucidate the relationships between standardized...
This federal Project Grant award of $824,284 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a longitudinal study investigating the relationship between residential segregation and accelerated biological aging among Black adults. The research aims to: 1) Determine the association between exposure to residential segregation and age acceleration over the adult life course; 2) Identify neighborhood-level mediators of this relationship;...
The University of Alabama at Birmingham (UAB) received a $661,845 Project Grant from the National Cancer Institute (NCI) under the federal Cancer Cause and Prevention Research program (CFDA 93.393) to investigate structural racism's impact on end-of-life care quality for children with cancer. The grant funds a 5-year study that will leverage data from the Children's Oncology Group's Project:EveryChild registry to examine how access to care, patient/family interactions with the healthcare system,...
This Project Grant award, funded by the National Cancer Institute (CFDA 93.396 Cancer Biology Research), will support research to investigate the biological mechanisms underlying racial disparities in head and neck cancer outcomes, particularly among Black patients. The $714,062 award to the Regents of the University of California, San Francisco, with a project period from Apr 2025 to Mar 2030, has two key objectives: Develop a prognostic model using gene expression signatures to predict...
This federal Project Grant award from the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) provides $1,165,096 to the Sloan-Kettering Institute for Cancer Research to investigate the social genomic mechanisms linking structural racism, perceived discrimination, and breast cancer survival. The key products and services to be delivered under this 5-year award include: 1) defining the contributions of objective structural...
This Cooperative Agreement award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), provides $1,620,203 to the University of Southern California (USC) to conduct a large-scale research study titled "Identifying Factors Associated with Prostate Cancer Progression and Survival in African American Men: The RESPOND Cohort." The key objectives of this project are to: Examine multi-level factors related to access to care...
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), will fund a $334,233 research project conducted by the University of South Carolina. The project aims to examine disparities in the use of novel cancer therapies, as well as the impacts of comorbidities and multilevel factors on treatment outcomes and survival trajectories for lung and colon cancer patients, particularly among minority and rural...
This $1,742,902 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a research study to investigate racial/ethnic disparities in cardiovascular disease (CVD) risk factors and subclinical abnormalities among young adults with type 1 diabetes. The study will enroll 1,000 participants, including 300 Hispanic or non-Hispanic Black young adults, to rigorously assess CVD-related structural and...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $1,174,255 to the University of Pittsburgh to investigate racial and ethnic disparities in emergency medical services (EMS) interventions for out-of-hospital cardiac arrest (OHCA). The research aims to scrutinize differences in key EMS practices, such as time to defibrillation, epinephrine administration, and termination...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), provides $402,600 to the Fred Hutchinson Cancer Center in Seattle, Washington to conduct research on disparities in financial and clinical outcomes among commercially-insured cancer patients following the implementation of the Affordable Care Act (ACA). The key objectives of this 4-year study are to: 1) Understand how the characteristics of...

STRUCTURAL RACISM AND CARDIOVASCULAR OUTCOMES AMONG CANCER SURVIVORS - PROJECT SUMMARY/ABSTRACT AMONG INDIVIDUALS WHO SURVIVE 5 YEARS FROM A CANCER DIAGNOSIS, CARDIOVASCULAR DISEASE (CVD) IS THE LEADING CAUSE OF DEATH. BLACK ADULTS WITH CANCER HAVE TWICE THE RISK OF POOR CVD OUTCOMES AS WHITE ADULTS WITH CANCER. THIS DISPARITY IS PARTIALLY DUE TO A HIGHER CVD PREVALENCE AMONG BLACKS IN THE GENERAL POPULATION, AND GREATER INCIDENCE OF CARDIO-TOXIC EFFECTS FROM CANCER THERAPIES AMONG BLACKS, BUT WE HYPOTHESIZE THAT SOCIAL DETERMINANTS OF HEALTH (SDOHS) (E.G., AREA-LEVEL STRUCTURAL RACISM AND INDIVIDUAL SOCIO-ECONOMIC POSITION) ARE ALSO RESPONSIBLE FOR BLACK-WHITE CVD DISPARITIES. WE HAVE SHOWN THAT HAVING 1 ADVERSE SDOH INCREASES ONE'S RISK OF CANCER MORTALITY, AND BLACKS ARE MORE LIKELY TO HAVE 2 SDOHS THAN WHITES (44% VS. 24%). APART FROM CANCER, 1 SDOHS INCREASES ONE'S RISK OF CORONARY HEART DISEASE, STROKE, AND HEART FAILURE. UNDERLYING MECHANISMS OF SDOHS THAT LEAD TO CVD DISPARITIES IN CANCER SURVIVORS ARE NOT WELL UNDERSTOOD. STRUCTURAL RACISM HAS POLICY IMPLICATIONS AND UNDERSTANDING ITS ROLE IN BLACK-WHITE CVD DISPARITIES CAN POINT THE WAY TO SOLUTIONS TO REDUCE DISPARITIES. WE WILL USE THE WORLD HEALTH ORGANIZATION'S COMMISSION ON SDOH FRAMEWORK TO INVESTIGATE RELATIONSHIPS BETWEEN SDOHS AND CVD OUTCOMES IN BLACK AND WHITE CANCER SURVIVORS. THE OBJECTIVE OF THIS PROPOSAL IS TO DETERMINE THE ROLE OF SDOH (STRUCTURAL RACISM AND INDIVIDUAL SOCIO- ECONOMIC POSITION) ON CVD OUTCOMES AMONG A COMMUNITY-BASED COHORT OF 8,000 MALE AND FEMALE ADULTS WITH CANCER. WE SEEK TO LEVERAGE A NOVEL LINK BETWEEN DATA FROM THE REASONS FOR GEOGRAPHIC AND RACIAL DISPARITIES IN STROKE (REGARDS) STUDY TO CANCER REGISTRIES FROM THE VIRTUAL POOLED REGISTRY CANCER LINKAGE SYSTEM (VPR-CLS). REGARDS IS A NATIONAL, PROSPECTIVE, LONGITUDINAL COHORT STUDY THAT RECRUITED 30,239 ENGLISH-SPEAKING INDIVIDUALS, AT LEAST 45 YEARS OF AGE FROM THE 48 CONTIGUOUS US STATES (42% BLACK; 55% FEMALE) IN 2003-7 AND FOLLOWS PARTICIPANTS TODAY. THE VPR, COORDINATED BY THE NORTH AMERICAN ASSOCIATION OF CANCER REGISTRIES, INCLUDES 45 REGISTRIES COVERING 95% OF THE U.S. THE NOVEL COMBINATION OF DATA SOURCES WILL LEVERAGE AREA-LEVEL STRUCTURAL RACISM MEASURES AND INDIVIDUAL-LEVEL MEASURES OF SOCIO-ECONOMIC STATUS, CANCER BIOLOGIC FACTORS, HEALTH BEHAVIORS, SELF-RATED HEALTH, AND EXPERT ADJUDICATED CVD OUTCOMES TO DETERMINE AMONG CANCER SURVIVORS: 1) ASSOCIATIONS BETWEEN SDOH AND CVD OUTCOMES; 2) THE ROLE OF CANCER BIOLOGIC, BEHAVIORAL, AND PSYCHOSOCIAL FACTORS IN THE RELATIONSHIP BETWEEN SDOH AND CVD; AND 3) THE ROLE OF CANCER AND NON-CANCER HEALTH SERVICE USE IN THE RELATIONSHIP BETWEEN SDOH AND CVD. OUR LONG-TERM GOAL IS TO DEVELOP STRATEGIES TO ELIMINATE WHITE-BLACK DISPARITIES IN CVD OUTCOMES IN CANCER SURVIVORS. WE HAVE ASSEMBLED A MULTI-DISCIPLINARY TEAM OF EXPERTS IN CVD AND CANCER EPIDEMIOLOGY, HEALTH SERVICES RESEARCH, CARDIO-ONCOLOGY, BIOSTATISTICS, SDOH, AND STRUCTURAL RACISM. TOGETHER, WE WILL GENERATE EVIDENCE TO INFORM AND DEVELOP INTERVENTIONS TO ELIMINATE BLACK-WHITE CVD DISPARITIES IN CANCER SURVIVORSHIP.

Posted 5/6/24, 12:00 AM